IBD - Genes, bacteria and new therapeutic strategies

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


IBD is known to be associated with an abnormal response to an unbalanced gut microbiota in genetically predisposed individuals. The therapeutic goal now is to control progression of the disease. Given the heterogeneity of IBD, the two universes of basic and clinical science must work in parallel to realize the hope of personalized therapy.

Original languageEnglish
Pages (from-to)652-654
Number of pages3
JournalNature Reviews Gastroenterology and Hepatology
Issue number11
StatePublished - 5 Nov 2014


Dive into the research topics of 'IBD - Genes, bacteria and new therapeutic strategies'. Together they form a unique fingerprint.

Cite this